top of page

Katan Associates

NEWSROOM

Search

EAZE—SERVING 6 MILLION CUSTOMERS IN 100 CITIES IN SPITE OF COVID-19

Eaze’s innovative program is paving the way for a more equitable and inclusive future.

COVID-19, THE NEW NORMAL—AND A BETTER PATH

2020 YEAR OF THE SPAC

BIOTECH BOOMING DESPITE COVID-19 ECONOMY

Amivas Receives FDA Approval for Its Life-saving Treatment of Severe Malaria

MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market

Cannabis Sales Are Steady — for Now

The top 100 biopharma venture investors at the megabillions deal table

Warren Buffett’s Berkshire Hathaway settles on its first biotech investment

Planet MicroCap Showcase 2020

Coronavirus: Wuhan to Round Up the Infected for Mass Quarantine Camps

MedMen Announces Leadership Change

Insys founder Kapoor gets 5.5 years in prison for role in Subsys kickback scheme

Ipsen's $1B bet on the ropes after interim phase 3 analysis

Katan Associates Getting it Done at JPM!!!

Ameri Holdings to Merge with Jay Pharma Inc., Evidence-Based Cannabinoid Medicine & Wellness Company

Katan Associates Wins Life Sciences Strategic Consulting Firm Award

2019 Year in Review

QuickBox Fulfillment Announces Growth Investment by Pike Street Capital

bottom of page